Skip to content

AUPH

Aurinia Pharmaceuticals, Inc.

NASDAQ · Healthcare · Biotechnology · CA

$16.49
−0.12%
Ask drillr

Leverage

Debt / equity
0.10x
Net debt / equity
-0.19x
Debt / assets
0.08x
Debt / EBITDA
0.32x
Net debt / EBITDA
-0.63x

Liquidity & coverage

Current ratio
5.42x
Quick ratio
4.97x
Cash ratio
4.44x
Interest coverage
17.79x
EBITDA / interest
22.21x
Working capital
$441.4M

Cash & dividend

FCF / debt
2.87x
Cash flow / debt
2.88x
Dividend per share
—
Dividend yield
—
Dividend growth 1y
—

Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026